<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01383018</url>
  </required_header>
  <id_info>
    <org_study_id>U0552</org_study_id>
    <nct_id>NCT01383018</nct_id>
  </id_info>
  <brief_title>PROPPER Prospective Registry of Outcomes With Penile Prosthesis</brief_title>
  <acronym>PROPPER</acronym>
  <official_title>Prospective Registry of Outcomes With Penile Prosthesis for Erectile Restoration (PROPPER)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this observational registry is to collect and better understand &quot;real-world&quot;
      outcomes for men undergoing penile implant surgery to treat erectile dysfunction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, multi-center, observational registry to be conducted at multiple sites
      throughout the United States and Canada, to collect &quot;real-world&quot; penile prosthetic outcomes
      according to investigators' standard of care. Using questionnaires as well as electronic data
      collection, investigating physicians will prospectively measure patient responses at regular
      intervals over a one- to five year period. The physician researchers have identified key
      metrics for the study including effectiveness, durability, complications, and patient
      satisfaction; quality of life will also be analyzed, being defined through several validated
      patient surveys.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2011</start_date>
  <completion_date type="Actual">July 2018</completion_date>
  <primary_completion_date type="Actual">July 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Penile Prosthesis Overall Subject Satisfaction</measure>
    <time_frame>1 year, post-implantation</time_frame>
    <description>Penile prosthesis overall subject satisfaction (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Penile Prosthesis That Are Using the Device</measure>
    <time_frame>1 year, post implantation</time_frame>
    <description>Number of subjects using penile prosthesis at 1 year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.</measure>
    <time_frame>1 year, post implantation</time_frame>
    <description>Penile prosthesis use at year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Times Per Month Participants With Penile Prosthesis Are Using the Device.</measure>
    <time_frame>1 year, post implantation</time_frame>
    <description>Penile prosthesis use at 1 year measured in number of times per month (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-use</measure>
    <time_frame>1 year, post implantation</time_frame>
    <description>Penile prosthesis reasons for non-use at 1 year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Penile Prosthesis Using the Device But Not as Often as Desired</measure>
    <time_frame>1 year, post implantation</time_frame>
    <description>Number of penile prosthesis subjects using the device but indicated that they were not using as often as desired (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or Dissatisfied</measure>
    <time_frame>1 year, post implantation</time_frame>
    <description>Reason why subject is using penile prosthesis less than desired or dissatisfied (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Subject Reported 5-question International Index of Erectile Function (IIEF-5) Total Score, Baseline Through Five Years</measure>
    <time_frame>Baseline through 5 years</time_frame>
    <description>Penile prosthesis International Index of Erectile Function (IIEF-5) score (effectiveness objective 2) measured using a validated, multi-dimensional, self-administered questionnaire. Overall responses are reported. A higher score demonstrates an improvement in erectile function while a lower score indicates a loss of erectile function. The 5-question International Index of Erectile Function (IIEF-5) Questionnaire is a validated, multi-dimensional, self-administered investigation that has been found useful in the clinical assessment of erectile dysfunction and treatment outcomes in clinical trials. A score of 0 to 5 is awarded to each of the 5 questions that examine the 4 main domains of male sexual function: erectile function, orgasmic function, sexual desire, and intercourse satisfaction. The subscales are summed to calculated the total score. The minimum total score for this questionnaire is 0 with a maximum of 30.</description>
  </other_outcome>
  <other_outcome>
    <measure>Erection Hardness Scale Over Five Years</measure>
    <time_frame>Baseline through 5 years</time_frame>
    <description>The Erection Hardness Scale (EHS), an easy-to-use, four-point scale for erectile dysfunction, provides a reliable measure of erection hardness and an indicator of other health and wellbeing outcomes, according to new data reported at the European Association of Urology. EHS rates the hardness of erection on a scale of zero to four, with four being the maximal score. A higher score indicates a harder penis while a lower score indicates greater dysfunction.</description>
  </other_outcome>
  <other_outcome>
    <measure>American Urology Association - Symptom Index Over Five Years</measure>
    <time_frame>Baseline through 5 years</time_frame>
    <description>The AUA-SI contains seven symptoms questions which include feeling of incomplete bladder emptying, frequency, intermittency, urgency, weak stream, straining and nocturia, each referring to during the last month, and each involving assignment of a score from 0 to 5 for a total score of maximum 35 points from &quot;non-missing&quot; items. The lower score means a better quality of life.</description>
  </other_outcome>
  <other_outcome>
    <measure>UCLA Prostate Cancer Index Over Five Years</measure>
    <time_frame>Baseline through 5 years</time_frame>
    <description>The University of California Los Angeles-Prostate Cancer Index -UCLA-PCI is a validated, twenty question questionnaire to asses impact of treatment for early stage prostate cancer on quality of life. The UCLA-PCI is analyzed in six sections, Sexual Function and Sexual Bother, Urinary Function and Urinary Bother, and Bowel Function and Bowel Bother. This is to measure not just the impact on function but also the quality of life impact. The UCLA PCI domain is scored on a scale of 0-100 points with higher values representing better outcomes.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1457</enrollment>
  <condition>Erectile Dysfunction</condition>
  <condition>Impotence</condition>
  <arm_group>
    <arm_group_label>AMS penile prosthesis receipients</arm_group_label>
    <description>Men for whom an AMS penile prosthesis is recommended</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AMS Penile Prosthesis Devices</intervention_name>
    <description>Non-interventional device registry. Outcomes for patients receiving marketed AMS penile prosthesis devices.</description>
    <arm_group_label>AMS penile prosthesis receipients</arm_group_label>
    <other_name>AMS 700</other_name>
    <other_name>AMS Ambicor</other_name>
    <other_name>AMS Spectra</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Men with ED in the United States and Canada.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Men diagnosed with erectile dysfunction (ED) for whom an AMS penile prosthesis is
        recommended by their physician are eligible for inclusion. Potentially eligible men should
        also meet the following inclusion criteria for study enrollment:

          -  Willing and able to provide written informed consent prior to enrollment (if
             applicable).

          -  Willing to be seen or contacted by phone by the investigator and answer at least 2
             questions related to satisfaction and device use 1 year following implantation of an
             AMS penile prosthesis.

        Exclusion Criteria:

        - Men who are deemed by their physician to be not suitable for a penile implant will be
        excluded.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerard Henry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ark-LA-Tek</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anthony J. Bella, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Ottawa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edward Karpman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>El Camino Urology Medical Group</affiliation>
  </overall_official>
  <overall_official>
    <last_name>LeRoy Jones, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Urology San Antonio Research PA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bryan T Kansas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Urology Team</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brian Christine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Urology Centers of Alabama</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kevin McVary, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SIU School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Hotaling, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohit Khera, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eugene Rhee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaiser Permanente</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Urology Centers of Alabama</name>
      <address>
        <city>Homewood</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>El Camino Urology Medical Group</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>94040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92154</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SIU School of Medicine</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62794-9664</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ark-LA-Tek</name>
      <address>
        <city>Bossier City</city>
        <state>Louisiana</state>
        <zip>71111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lahey Clinic</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Urology Team</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78715</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Urology San Antonio Research, PA</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Ottawa</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>June 24, 2011</study_first_submitted>
  <study_first_submitted_qc>June 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2011</study_first_posted>
  <results_first_submitted>December 16, 2019</results_first_submitted>
  <results_first_submitted_qc>February 5, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 18, 2020</results_first_posted>
  <last_update_submitted>February 5, 2020</last_update_submitted>
  <last_update_submitted_qc>February 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Erectile Dysfunction (ED)</keyword>
  <keyword>Penile Implant</keyword>
  <keyword>Impotence</keyword>
  <keyword>Penile Prosthesis</keyword>
  <keyword>Registry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 17, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/18/NCT01383018/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>AMS Penile Prosthesis Recipients</title>
          <description>Men for whom an AMS penile prosthesis is recommended
AMS Penile Prosthesis Devices: Non-interventional device registry. Outcomes for patients receiving marketed AMS penile prosthesis devices.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1457"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1082"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="375"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject not implanted</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missed Visit</title>
              <participants_list>
                <participants group_id="P1" count="247"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Site closed early-not compliance related</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Patient moved away from site</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject Incarcerated</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>AMS penile prosthesis recipients that completed baseline assessments. Subjects that started the study but did not have implantation are not included.</population>
      <group_list>
        <group group_id="B1">
          <title>AMS Penile Prosthesis Recipients</title>
          <description>Men for whom an AMS penile prosthesis is recommended
AMS Penile Prosthesis Devices: Non-interventional device registry. Outcomes for patients receiving marketed AMS penile prosthesis devices.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1380"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.8" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1380"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1303"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="187"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1152"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primary ED etiology</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Radical prostatectomy (RP)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="369"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Diabetes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="283"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Cardiovascular disease</title>
                  <measurement_list>
                    <measurement group_id="B1" value="251"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Peyronies disease</title>
                  <measurement_list>
                    <measurement group_id="B1" value="123"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Priaprism</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="335"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Penile Prosthesis Overall Subject Satisfaction</title>
        <description>Penile prosthesis overall subject satisfaction (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
        <time_frame>1 year, post-implantation</time_frame>
        <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>All AMS Penile Prosthesis Recipients - Total Reponses</title>
            <description>Men for whom an AMS penile prosthesis is recommended
AMS Penile Prostheses: Non-interventional device registry. Outcomes for subjects receiving a marketed AMS penile prosthesis.</description>
          </group>
          <group group_id="O2">
            <title>AMS 700</title>
            <description>AMS 700, only
Men for whom an AMS 700 penile prosthesis was recommended</description>
          </group>
          <group group_id="O3">
            <title>AMS Ambicor</title>
            <description>AMS Ambicor, only
Men for whom an AMS Ambicor penile prosthesis was recommended</description>
          </group>
          <group group_id="O4">
            <title>Spectra</title>
            <description>Spectra, only
Men for whom a Spectra penile prosthesis was recommended</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Penile Prosthesis Overall Subject Satisfaction</title>
          <description>Penile prosthesis overall subject satisfaction (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
          <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1082"/>
                <count group_id="O2" value="1050"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Very Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="35"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Neither Satisfied nor Dissatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="71"/>
                    <measurement group_id="O2" value="68"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="297"/>
                    <measurement group_id="O2" value="286"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="643"/>
                    <measurement group_id="O2" value="627"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Penile Prosthesis That Are Using the Device</title>
        <description>Number of subjects using penile prosthesis at 1 year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
        <time_frame>1 year, post implantation</time_frame>
        <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>All AMS Penile Prosthesis Recipients - Total Reponses</title>
            <description>Men for whom an AMS penile prosthesis is recommended
AMS Penile Prostheses: Non-interventional device registry. Outcomes for subjects receiving a marketed AMS penile prosthesis.</description>
          </group>
          <group group_id="O2">
            <title>AMS 700</title>
            <description>AMS 700, only
Men for whom an AMS 700 penile prosthesis was recommended</description>
          </group>
          <group group_id="O3">
            <title>AMS Ambicor</title>
            <description>AMS Ambicor, only
Men for whom an AMS Ambicor penile prosthesis was recommended</description>
          </group>
          <group group_id="O4">
            <title>Spectra</title>
            <description>Spectra, only
Men for whom a Spectra penile prosthesis was recommended</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Penile Prosthesis That Are Using the Device</title>
          <description>Number of subjects using penile prosthesis at 1 year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
          <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1082"/>
                <count group_id="O2" value="1050"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="984"/>
                    <measurement group_id="O2" value="956"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.</title>
        <description>Penile prosthesis use at year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
        <time_frame>1 year, post implantation</time_frame>
        <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit who answered that they were using the device and responded to how often they were using it.</population>
        <group_list>
          <group group_id="O1">
            <title>All AMS Penile Prosthesis Recipients - Total Reponses</title>
            <description>Men for whom an AMS penile prosthesis is recommended
AMS Penile Prostheses: Non-interventional device registry. Outcomes for subjects receiving a marketed AMS penile prosthesis.</description>
          </group>
          <group group_id="O2">
            <title>AMS 700</title>
            <description>AMS 700, only
Men for whom an AMS 700 penile prosthesis was recommended</description>
          </group>
          <group group_id="O3">
            <title>AMS Ambicor</title>
            <description>AMS Ambicor, only
Men for whom an AMS Ambicor penile prosthesis was recommended</description>
          </group>
          <group group_id="O4">
            <title>Spectra</title>
            <description>Spectra, only
Men for whom a Spectra penile prosthesis was recommended</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.</title>
          <description>Penile prosthesis use at year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
          <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit who answered that they were using the device and responded to how often they were using it.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="895"/>
                <count group_id="O2" value="867"/>
                <count group_id="O3" value="18"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Less than once per month</title>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="56"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than once per month</title>
                  <measurement_list>
                    <measurement group_id="O1" value="837"/>
                    <measurement group_id="O2" value="811"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Times Per Month Participants With Penile Prosthesis Are Using the Device.</title>
        <description>Penile prosthesis use at 1 year measured in number of times per month (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
        <time_frame>1 year, post implantation</time_frame>
        <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit who hand answered that they were using the device and responded to how many times per month they were using it.</population>
        <group_list>
          <group group_id="O1">
            <title>All AMS Penile Prosthesis Recipients - Total Reponses</title>
            <description>Men for whom an AMS penile prosthesis is recommended
AMS Penile Prostheses: Non-interventional device registry. Outcomes for subjects receiving a marketed AMS penile prosthesis.</description>
          </group>
          <group group_id="O2">
            <title>AMS 700</title>
            <description>AMS 700, only
Men for whom an AMS 700 penile prosthesis was recommended</description>
          </group>
          <group group_id="O3">
            <title>AMS Ambicor</title>
            <description>AMS Ambicor, only
Men for whom an AMS Ambicor penile prosthesis was recommended</description>
          </group>
          <group group_id="O4">
            <title>Spectra</title>
            <description>Spectra, only
Men for whom a Spectra penile prosthesis was recommended</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Times Per Month Participants With Penile Prosthesis Are Using the Device.</title>
          <description>Penile prosthesis use at 1 year measured in number of times per month (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
          <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit who hand answered that they were using the device and responded to how many times per month they were using it.</population>
          <units>Number of times per month</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="490"/>
                <count group_id="O2" value="467"/>
                <count group_id="O3" value="17"/>
                <count group_id="O4" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" spread="5.5"/>
                    <measurement group_id="O2" value="6.3" spread="5.6"/>
                    <measurement group_id="O3" value="5.4" spread="3.3"/>
                    <measurement group_id="O4" value="5.2" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-use</title>
        <description>Penile prosthesis reasons for non-use at 1 year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
        <time_frame>1 year, post implantation</time_frame>
        <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit who had answered that they were not using the device and responded to the reason for non-use.</population>
        <group_list>
          <group group_id="O1">
            <title>All AMS Penile Prosthesis Recipients - Total Reponses</title>
            <description>Men for whom an AMS penile prosthesis is recommended
AMS Penile Prostheses: Non-interventional device registry. Outcomes for subjects receiving a marketed AMS penile prosthesis.</description>
          </group>
          <group group_id="O2">
            <title>AMS 700</title>
            <description>AMS 700, only
Men for whom an AMS 700 penile prosthesis was recommended</description>
          </group>
          <group group_id="O3">
            <title>AMS Ambicor</title>
            <description>AMS Ambicor, only
Men for whom an AMS Ambicor penile prosthesis was recommended</description>
          </group>
          <group group_id="O4">
            <title>Spectra</title>
            <description>Spectra, only
Men for whom a Spectra penile prosthesis was recommended</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-use</title>
          <description>Penile prosthesis reasons for non-use at 1 year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
          <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit who had answered that they were not using the device and responded to the reason for non-use.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="89"/>
                <count group_id="O2" value="87"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Loss of partner</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Partner disinterest</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Device problem</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Device dissatisfaction</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Health decline</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other reason</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Penile Prosthesis Using the Device But Not as Often as Desired</title>
        <description>Number of penile prosthesis subjects using the device but indicated that they were not using as often as desired (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
        <time_frame>1 year, post implantation</time_frame>
        <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>All AMS Penile Prosthesis Recipients - Total Reponses</title>
            <description>Men for whom an AMS penile prosthesis is recommended
AMS Penile Prostheses: Non-interventional device registry. Outcomes for subjects receiving a marketed AMS penile prosthesis.</description>
          </group>
          <group group_id="O2">
            <title>AMS 700</title>
            <description>AMS 700, only
Men for whom an AMS 700 penile prosthesis was recommended</description>
          </group>
          <group group_id="O3">
            <title>AMS Ambicor</title>
            <description>AMS Ambicor, only
Men for whom an AMS Ambicor penile prosthesis was recommended</description>
          </group>
          <group group_id="O4">
            <title>Spectra</title>
            <description>Spectra, only
Men for whom a Spectra penile prosthesis was recommended</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Penile Prosthesis Using the Device But Not as Often as Desired</title>
          <description>Number of penile prosthesis subjects using the device but indicated that they were not using as often as desired (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
          <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1082"/>
                <count group_id="O2" value="1050"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109"/>
                    <measurement group_id="O2" value="96"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or Dissatisfied</title>
        <description>Reason why subject is using penile prosthesis less than desired or dissatisfied (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
        <time_frame>1 year, post implantation</time_frame>
        <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit and responded that they were using the device less than desired or dissatisfied.</population>
        <group_list>
          <group group_id="O1">
            <title>All AMS Penile Prosthesis Recipients - Total Reponses</title>
            <description>Men for whom an AMS penile prosthesis is recommended
AMS Penile Prostheses: Non-interventional device registry. Outcomes for subjects receiving a marketed AMS penile prosthesis.</description>
          </group>
          <group group_id="O2">
            <title>AMS 700</title>
            <description>AMS 700, only
Men for whom an AMS 700 penile prosthesis was recommended</description>
          </group>
          <group group_id="O3">
            <title>AMS Ambicor</title>
            <description>AMS Ambicor, only
Men for whom an AMS Ambicor penile prosthesis was recommended</description>
          </group>
          <group group_id="O4">
            <title>Spectra</title>
            <description>Spectra, only
Men for whom a Spectra penile prosthesis was recommended</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or Dissatisfied</title>
          <description>Reason why subject is using penile prosthesis less than desired or dissatisfied (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.</description>
          <population>Subjects who received an AMS penile prosthesis and completed 1 year follow-up visit and responded that they were using the device less than desired or dissatisfied.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
                <count group_id="O2" value="117"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Loss of partner</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Partner disinterest</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Device problem</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Device dissatisfaction</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Health decline</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other reason</title>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                    <measurement group_id="O2" value="74"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Subject Reported 5-question International Index of Erectile Function (IIEF-5) Total Score, Baseline Through Five Years</title>
        <description>Penile prosthesis International Index of Erectile Function (IIEF-5) score (effectiveness objective 2) measured using a validated, multi-dimensional, self-administered questionnaire. Overall responses are reported. A higher score demonstrates an improvement in erectile function while a lower score indicates a loss of erectile function. The 5-question International Index of Erectile Function (IIEF-5) Questionnaire is a validated, multi-dimensional, self-administered investigation that has been found useful in the clinical assessment of erectile dysfunction and treatment outcomes in clinical trials. A score of 0 to 5 is awarded to each of the 5 questions that examine the 4 main domains of male sexual function: erectile function, orgasmic function, sexual desire, and intercourse satisfaction. The subscales are summed to calculated the total score. The minimum total score for this questionnaire is 0 with a maximum of 30.</description>
        <time_frame>Baseline through 5 years</time_frame>
        <population>Number of subjects analyzed reduced over time due to attrition. Also, follow-up after 1 year was optional.</population>
        <group_list>
          <group group_id="O1">
            <title>All AMS Penile Prosthesis Recipients - Total Reponses</title>
            <description>Men for whom an AMS penile prosthesis was recommended
AMS Penile Prosthesis Devices: Non-interventional device registry. Outcomes for patients receiving a marketed AMS penile prosthesis.</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Reported 5-question International Index of Erectile Function (IIEF-5) Total Score, Baseline Through Five Years</title>
          <description>Penile prosthesis International Index of Erectile Function (IIEF-5) score (effectiveness objective 2) measured using a validated, multi-dimensional, self-administered questionnaire. Overall responses are reported. A higher score demonstrates an improvement in erectile function while a lower score indicates a loss of erectile function. The 5-question International Index of Erectile Function (IIEF-5) Questionnaire is a validated, multi-dimensional, self-administered investigation that has been found useful in the clinical assessment of erectile dysfunction and treatment outcomes in clinical trials. A score of 0 to 5 is awarded to each of the 5 questions that examine the 4 main domains of male sexual function: erectile function, orgasmic function, sexual desire, and intercourse satisfaction. The subscales are summed to calculated the total score. The minimum total score for this questionnaire is 0 with a maximum of 30.</description>
          <population>Number of subjects analyzed reduced over time due to attrition. Also, follow-up after 1 year was optional.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1194"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1194"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.4" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="853"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.6" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="777"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.4" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="595"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.2" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="457"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.6" spread="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="291"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.2" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Erection Hardness Scale Over Five Years</title>
        <description>The Erection Hardness Scale (EHS), an easy-to-use, four-point scale for erectile dysfunction, provides a reliable measure of erection hardness and an indicator of other health and wellbeing outcomes, according to new data reported at the European Association of Urology. EHS rates the hardness of erection on a scale of zero to four, with four being the maximal score. A higher score indicates a harder penis while a lower score indicates greater dysfunction.</description>
        <time_frame>Baseline through 5 years</time_frame>
        <population>Number of subjects analyzed reduced over time due to attrition. Also, follow-up after 1 year was optional.</population>
        <group_list>
          <group group_id="O1">
            <title>All AMS Penile Prosthesis Recipients - Total Reponses</title>
            <description>Men for whom an AMS penile prosthesis was recommended
AMS Penile Prosthesis Devices: Non-interventional device registry. Outcomes for patients receiving a marketed AMS penile prosthesis.</description>
          </group>
        </group_list>
        <measure>
          <title>Erection Hardness Scale Over Five Years</title>
          <description>The Erection Hardness Scale (EHS), an easy-to-use, four-point scale for erectile dysfunction, provides a reliable measure of erection hardness and an indicator of other health and wellbeing outcomes, according to new data reported at the European Association of Urology. EHS rates the hardness of erection on a scale of zero to four, with four being the maximal score. A higher score indicates a harder penis while a lower score indicates greater dysfunction.</description>
          <population>Number of subjects analyzed reduced over time due to attrition. Also, follow-up after 1 year was optional.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1209"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1209"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="855"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="779"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="594"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="462"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="289"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>American Urology Association - Symptom Index Over Five Years</title>
        <description>The AUA-SI contains seven symptoms questions which include feeling of incomplete bladder emptying, frequency, intermittency, urgency, weak stream, straining and nocturia, each referring to during the last month, and each involving assignment of a score from 0 to 5 for a total score of maximum 35 points from &quot;non-missing&quot; items. The lower score means a better quality of life.</description>
        <time_frame>Baseline through 5 years</time_frame>
        <population>Number of subjects analyzed reduced over time due to attrition. Also, follow-up after 1 year was optional.</population>
        <group_list>
          <group group_id="O1">
            <title>All AMS Penile Prosthesis Recipients - Total Reponses</title>
            <description>Men for whom an AMS penile prosthesis was recommended
AMS Penile Prosthesis Devices: Non-interventional device registry. Outcomes for patients receiving a marketed AMS penile prosthesis.</description>
          </group>
        </group_list>
        <measure>
          <title>American Urology Association - Symptom Index Over Five Years</title>
          <description>The AUA-SI contains seven symptoms questions which include feeling of incomplete bladder emptying, frequency, intermittency, urgency, weak stream, straining and nocturia, each referring to during the last month, and each involving assignment of a score from 0 to 5 for a total score of maximum 35 points from &quot;non-missing&quot; items. The lower score means a better quality of life.</description>
          <population>Number of subjects analyzed reduced over time due to attrition. Also, follow-up after 1 year was optional.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1114"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1114"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.0" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="805"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="741"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8" spread="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="564"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.2" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="433"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="281"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>UCLA Prostate Cancer Index Over Five Years</title>
        <description>The University of California Los Angeles-Prostate Cancer Index -UCLA-PCI is a validated, twenty question questionnaire to asses impact of treatment for early stage prostate cancer on quality of life. The UCLA-PCI is analyzed in six sections, Sexual Function and Sexual Bother, Urinary Function and Urinary Bother, and Bowel Function and Bowel Bother. This is to measure not just the impact on function but also the quality of life impact. The UCLA PCI domain is scored on a scale of 0-100 points with higher values representing better outcomes.</description>
        <time_frame>Baseline through 5 years</time_frame>
        <population>Number of subjects analyzed reduced over time due to attrition. Also, follow-up after 1 year was optional.</population>
        <group_list>
          <group group_id="O1">
            <title>UCLA-PCI Sexual Function</title>
            <description>Sexual function measure</description>
          </group>
          <group group_id="O2">
            <title>UCLA-PCI Urinary Function</title>
            <description>Urinary function measure</description>
          </group>
          <group group_id="O3">
            <title>UCLA-PCI Bowel Function</title>
            <description>Bowel function measure</description>
          </group>
          <group group_id="O4">
            <title>UCLA-PCI Sexual Bother</title>
            <description>Sexual bother measure</description>
          </group>
          <group group_id="O5">
            <title>UCLA-PCI Urinary Bother</title>
            <description>Urinary bother measure</description>
          </group>
          <group group_id="O6">
            <title>UCLA-PCI Bowel Bother</title>
            <description>Bowel bother measure</description>
          </group>
        </group_list>
        <measure>
          <title>UCLA Prostate Cancer Index Over Five Years</title>
          <description>The University of California Los Angeles-Prostate Cancer Index -UCLA-PCI is a validated, twenty question questionnaire to asses impact of treatment for early stage prostate cancer on quality of life. The UCLA-PCI is analyzed in six sections, Sexual Function and Sexual Bother, Urinary Function and Urinary Bother, and Bowel Function and Bowel Bother. This is to measure not just the impact on function but also the quality of life impact. The UCLA PCI domain is scored on a scale of 0-100 points with higher values representing better outcomes.</description>
          <population>Number of subjects analyzed reduced over time due to attrition. Also, follow-up after 1 year was optional.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="833"/>
                <count group_id="O2" value="814"/>
                <count group_id="O3" value="804"/>
                <count group_id="O4" value="820"/>
                <count group_id="O5" value="812"/>
                <count group_id="O6" value="802"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="833"/>
                    <count group_id="O2" value="814"/>
                    <count group_id="O3" value="804"/>
                    <count group_id="O4" value="820"/>
                    <count group_id="O5" value="812"/>
                    <count group_id="O6" value="802"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.5" spread="16.9"/>
                    <measurement group_id="O2" value="79.9" spread="24.3"/>
                    <measurement group_id="O3" value="85.0" spread="15.5"/>
                    <measurement group_id="O4" value="10.8" spread="22.8"/>
                    <measurement group_id="O5" value="76.7" spread="31.6"/>
                    <measurement group_id="O6" value="85.5" spread="24.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="619"/>
                    <count group_id="O2" value="616"/>
                    <count group_id="O3" value="613"/>
                    <count group_id="O4" value="614"/>
                    <count group_id="O5" value="615"/>
                    <count group_id="O6" value="614"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.9" spread="20.9"/>
                    <measurement group_id="O2" value="82.6" spread="20.9"/>
                    <measurement group_id="O3" value="88.4" spread="14.3"/>
                    <measurement group_id="O4" value="77.3" spread="32.7"/>
                    <measurement group_id="O5" value="81.1" spread="26.6"/>
                    <measurement group_id="O6" value="87.3" spread="22.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="619"/>
                    <count group_id="O2" value="616"/>
                    <count group_id="O3" value="614"/>
                    <count group_id="O4" value="611"/>
                    <count group_id="O5" value="617"/>
                    <count group_id="O6" value="614"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.0" spread="21.6"/>
                    <measurement group_id="O2" value="83.4" spread="20.8"/>
                    <measurement group_id="O3" value="87.8" spread="15.9"/>
                    <measurement group_id="O4" value="77.9" spread="33.2"/>
                    <measurement group_id="O5" value="80.5" spread="27.3"/>
                    <measurement group_id="O6" value="86.5" spread="23.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="494"/>
                    <count group_id="O2" value="487"/>
                    <count group_id="O3" value="486"/>
                    <count group_id="O4" value="488"/>
                    <count group_id="O5" value="487"/>
                    <count group_id="O6" value="486"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.7" spread="20.8"/>
                    <measurement group_id="O2" value="83.8" spread="21.2"/>
                    <measurement group_id="O3" value="87.5" spread="17.1"/>
                    <measurement group_id="O4" value="78.8" spread="32.2"/>
                    <measurement group_id="O5" value="79.0" spread="28.3"/>
                    <measurement group_id="O6" value="86.8" spread="23.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="403"/>
                    <count group_id="O2" value="401"/>
                    <count group_id="O3" value="404"/>
                    <count group_id="O4" value="401"/>
                    <count group_id="O5" value="402"/>
                    <count group_id="O6" value="403"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.3" spread="22.2"/>
                    <measurement group_id="O2" value="86.0" spread="19.6"/>
                    <measurement group_id="O3" value="87.8" spread="17.3"/>
                    <measurement group_id="O4" value="80.7" spread="31.9"/>
                    <measurement group_id="O5" value="79.9" spread="27.3"/>
                    <measurement group_id="O6" value="86.6" spread="24.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="261"/>
                    <count group_id="O2" value="261"/>
                    <count group_id="O3" value="261"/>
                    <count group_id="O4" value="261"/>
                    <count group_id="O5" value="262"/>
                    <count group_id="O6" value="261"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.2" spread="21.3"/>
                    <measurement group_id="O2" value="85.9" spread="21.5"/>
                    <measurement group_id="O3" value="86.7" spread="19.3"/>
                    <measurement group_id="O4" value="83.1" spread="29.4"/>
                    <measurement group_id="O5" value="80.5" spread="28.3"/>
                    <measurement group_id="O6" value="84.8" spread="26.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected for all subjects who had the study device implanted through optional 5 year follow-up.</time_frame>
      <desc>All device and/or procedure related events were collected for this study.</desc>
      <group_list>
        <group group_id="E1">
          <title>AMS Penile Prosthesis Receipients</title>
          <description>Men for whom an AMS penile prosthesis is recommended
AMS Penile Prosthesis Devices: Non-interventional device registry. Outcomes for patients receiving marketed AMS penile prosthesis devices.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Other - Substernal Chest Pain</sub_title>
                <description>The event was reported by the site as not procedure or device related which does not fit the definition of a reportable SADE or UADE per the protocol.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pain/Discomfort - Penile</sub_title>
                <description>1 pain/discomfort-penile event, device and procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Pain/Discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Device Infection</sub_title>
                <description>13 Device Infections, 10 were device related, 5 were procedure related, 3 of these were related to both device and procedure. All events were resolved.</description>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <description>2 Abscess, 2 were device related with 1 being determined to also be procedure related. All events were resolved.</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <description>1 cellulitis event, procedure related.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Erosion</sub_title>
                <description>6 Erosion, 6 were device related with 2 being determined to also be procedure related All events were resolved.</description>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Reservoir Herniation</sub_title>
                <description>3 Reservoir Herniation, 2 were device related, 1 was procedure related. All events were resolved.</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <description>2 Hematoma events, 2 were procedure related, 1 was related to both device and procedure.</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Pain/Discomfort</sub_title>
                <description>1 Pain/Discomfort events, device related.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Cylinder Crossover</sub_title>
                <description>1 cylinder crossover event, device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Extrusion</sub_title>
                <description>1 extrusion event, device and procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Perforation - Other</sub_title>
                <description>1 perforation event, device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Proximal Corporal Perforation</sub_title>
                <description>1 proximal corporal perforation event, procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device Cylinder Aneruysm/Bulge</sub_title>
                <description>1 device cylinder aneurysm/bulge, device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Urethral Obstruction</sub_title>
                <description>1 urethral obstruction event, device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <description>2 urinary retention events, 1 was procedure related and 1 was device related.</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Peyronie's Disease</sub_title>
                <description>1 Peyronie's Disease event, device related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Other - Decreased Oxygen Saturation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Edema - Scrotal</sub_title>
                <description>1 edema - scrotal event, procedure and device related.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Would Dehiscence</sub_title>
                <description>1 wound dehiscence event, procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Event - Non-specific</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolus</sub_title>
                <description>1 pulmonary embolus event, procedure event</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="72" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pain/Discomfort</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Migration (pump)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Pain/Discomfort - Groin</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Pain/Discomfort - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Pain/Discomfort - Penile</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Pain/Discomfort With Erections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Patient Dissatisfaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Pain/Discomfort - Testicular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Other - Pinching sensation around the resevoirs</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic reaction/Hypersensitivity Reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Device Infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Superficial Wound Infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection - UTI</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Other - Incisional drainage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Erosion</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Reservoir Herniation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Urethral Trauma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Extrusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Device Placement Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Fibrous Capsule Formation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Perforation - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Proximal Corporal Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Migration (Pump)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Other - Left distal tip migration with pain at tip of penis with intercourse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Other - Change in curvature of penis (increase in curvature)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Other - Proximal cross over during IPP surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Other - Proximal crossover</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Inguinal Hernia Formation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Pain/Discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device Cylinder Aneurysm/Bulge</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Malposition</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Auto Inflation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Incorrect Size - Cylinders too Large</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Pain/Discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Migration (Pump)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Pain/Discomfort - Testicular</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Other - Buckling of left cylinder led to left downward curvature</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Other - Right cylinder protruding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Other - Bilateral corporal aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Bladder Neck Obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Priapism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Hematospermia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Peyronie's Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Other - Painful mass in right hemiscrotum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Adhesion of the Pump/Scrotum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Edema - Penile</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Wound Dehiscence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Pain/Discomfort - Groin</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
              <event>
                <sub_title>Other - Slight separation of penoscrotal wound</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Increased Blood Loss</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1380"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Amanda Vail, Clinical Project Manager</name_or_title>
      <organization>Boston Scientific</organization>
      <phone>612-749-5366</phone>
      <email>amanda.vail@bsci.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

